Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

73.7K
Overview
73.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

7.0K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
7.0K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

4.7K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

2.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

506
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
506

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Inherent tissue homeostasis of the juvenile metaphysis provides a foundation for osteosarcoma development.

Nature communications·2026
Same author

Self-reinforcing IL-1β signaling accelerates the development and recurrence of TCF3::HLF-positive B-ALL.

Blood·2026
Same author

Hypoxia drives progression of multiple sclerosis by enhancing the inflammasome activation in macrophages with Porphyromonas gingivalis infection.

Cell death discovery·2025
Same author

Fam102a translocates Runx2 and Rbpjl to facilitate Osterix expression and bone formation.

Nature communications·2025
Same author

RANK drives structured intestinal epithelial expansion during pregnancy.

Nature·2024
Same author

Correction: Crosstalk between bone and the immune system.

Journal of bone and mineral metabolism·2024

相关实验视频

Updated: Sep 17, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

542

骨之旅:OPN从骨到系统性免疫抑制的路径

Kyoko Hashimoto1, Kazuo Okamoto2,3, Hiroshi Takayanagi1

  • 1Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Cancer research
|June 30, 2025
PubMed
概括

骨转移抑制了抗癌免疫力,并阻碍了免疫检查点阻塞 (ICB) 治疗. 向骨质细胞和骨质素 (OPN) 可以恢复T细胞功能并提高ICB治疗的有效性.

更多相关视频

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.7K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.9K

相关实验视频

Last Updated: Sep 17, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

542
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.7K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.9K

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 骨质免疫学 骨质免疫学

背景情况:

  • 免疫检查点阻塞 (ICB) 疗法已经改变了癌症治疗,但面临阻力.
  • 抵抗的机制,特别是在骨转移的背景下,需要进一步阐明.

研究的目的:

  • 研究骨转移如何影响全身抗瘤免疫和ICB反应.
  • 确定骨微环境影响T细胞功能和ICB疗效的分子机制.

主要方法:

  • 对有骨转移的临床患者队列的分析.
  • 涉及骨质细胞衍生骨质素 (OPN) 和T细胞分化的机制研究.
  • 临床前癌症模型评估针对骨质细胞的治疗干预措施.

主要成果:

  • 患有骨转移的患者对ICB的反应减少.
  • 骨转移促进骨质细胞的骨质 (OPN) 生产,从而损害T细胞的分化.
  • 在临床前模型中准骨质细胞或OPN恢复了T细胞功能并改善了ICB疗效.

结论:

  • 骨转移积极抑制全身抗瘤免疫力,有助于ICB抗性.
  • 由骨质细胞分泌的骨质素 (OPN) 通过骨微环境之外的免疫抑制进行调解.
  • 准骨免疫轴是一个有前途的策略,可以在患有骨转移的患者中克服ICB抵抗.